Comunicati.net - Comunicati pubblicati - pbi Comunicati.net - Comunicati pubblicati - pbi Wed, 15 Aug 2018 18:30:30 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/utenti/24008/1 2018 - 2024 Veterinary Wound Care Market | Precision Business Insights Thu, 05 Jul 2018 10:40:45 +0200 http://comunicati.net/comunicati/aziende/editoria/485325.html http://comunicati.net/comunicati/aziende/editoria/485325.html pbi pbi

 

Global Veterinary Wound Care Market: By Type (Surgical Wound Care Products, Advanced Wound Care Products, Traditional Wound Care Products), By Products (Dressings, Adsorbents, Sutures, Staplers, Sealants, Tissue Adhesives, Glues, Others), By Animal Type (Ruminants, Equine, Canine, Feline, Swine, Others), By End User (Veterinary Hospitals, Veterinary Clinics), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 

Market Dynamics: Veterinary Wound Care Market

 

Growing pet adoption is the major driving factor of the veterinary wound care market. Furthermore, rise in incidence of wounds in pets, rise in innovative technologies and products in animal wound care, rise in R&D investments on veterinary wound care products expected to boost the market for veterinary wound care. Growing awareness regarding pet insurance, increase in number of animal care organizations, and growing expenditure on pet healthcare will have positive impact on veterinary wound care market growth. However, lack of awareness regarding the animal health, high costs of products and treatments, shortage of veterinary practitioners may hamper the growth of veterinary wound care market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/veterinary-wound-care-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Veterinary Wound Care Market

Veterinary Wound Care market is segmented on the basis of Type, Products, Animal Type, and Distribution channel and Geographical regions

Based on the Type, This market is segmented into the following:

·         Surgical Wound Care Products

·         Advanced Wound Care Products

·         Traditional Wound Care Products

Based on the Products, This market is segmented into the following:

·         Dressings

·         Adsorbents

·         Sutures

·         Staplers

·         Sealants

·         Tissue Adhesives

·         Glues

·         Others

Based on the Animal Type, This market is segmented into the following:

·         Ruminants

·         Equine

·         Canine

·         Feline

·         Swine

·         Others

Based on the End User, This market is segmented into the following:

·         Veterinary Hospitals

·         Veterinary Clinics

 

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/veterinary-wound-care-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Veterinary Wound Care Market

Veterinary Wound Care market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa regions. Veterinary Wound Care market is dominated by North America followed by Europe due to the increasing practitioners in veterinary and well established veterinary healthcare in those regions. Due to the increase in adoption of animals, growing health concerns about the pets and humanization of animals are expected to offer lucrative opportunities for Asia pacific veterinary wound care market.

Competition Assessment: Veterinary Wound Care Market

Key players profiled in the global Veterinary Wound Care market include:

·         Medtronic plc. (Ireland)

·         3M Company (U.S.)

·         Ethicon Inc. (U.S.)

·         B Braun Melsungen AG (Germany)

·         Jorgen Kruuse A/S (Denmark)

·         Virbac (France)

·         Neogen Corporation (U.S.)

·         Acelity L.P. Inc. (U.S.)

·         Bayer AG (Germany)

·         Robinson Healthcare Limited (UK)

·         Advancis Veterinary Ltd. (UK)

 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/veterinary-wound-care-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/veterinary-wound-care-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

]]>
2018 - 2024 Big Data in Healthcare Market | Precision Business Insights Thu, 05 Jul 2018 09:37:45 +0200 http://comunicati.net/comunicati/aziende/editoria/485307.html http://comunicati.net/comunicati/aziende/editoria/485307.html pbi pbi

 

Global Big Data in Healthcare Market: By Product Type (Software, Hardware, Services), By Deployment Mode (On-Premise, Cloud), By Application (Clinical Data Analytics, Operational Analytics, Financial Analytics), By End Users (Hospitals, Insurance & Finance Agencies, Research organizations), and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Market Outline: Big Data in Healthcare Market

 

Big data in healthcare refers to the large set of structured and unstructured data that can be assessed to disclose the trends and patterns in healthcare system for present and future. It also provides the complete data on healthcare related processes such as pre-hospitalization to post medical cost analysis. Big data in healthcare used to predict the epidemics, supporting clinical decisions, enhance the quality of life, and avoid the preventable deaths. The major applications of big data in healthcare include financial analytics, clinical data analytics, and operational analytics.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/big-data-in-healthcare-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Dynamics: Big Data in Healthcare Market

Drivers:

·         Extensive use of cloud-based deployment

·         Increase in the demand for integration of big data analytics in healthcare segment

·         Technological advancements such as mHealth

Restraints:

·         Insecurity in data storage

·         Lack of IT infrastructure in Underdeveloped Countries

·         High cost of initial investment

 

Market Scope: Big Data in Healthcare Market

Big data in healthcare market is segmented on the basis of product type, deployment mode, application, end user, and region

Based on the product type, big data in healthcare market is segmented into the following:

·         Software

·         Hardware

·         Services

Based on the deployment mode, big data in healthcare market is segmented into the following:

·         On-premise

·         Cloud

Based on the application, big data in healthcare market is segmented into the following:

·         Clinical Data Analytics

·         Operational Analytics

·         Financial Analytics

Based on the end user, big data in healthcare market is segmented into the following:

·         Hospitals

·         Insurance & Finance Agencies

·         Research organizations

Based on the region, big data in healthcare market is segmented into the following:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/big-data-in-healthcare-market/#ulp-c654SbFYO64MsOhu

 

Competition Assessment: Big Data in Healthcare Market

Some of the players in the global big data in healthcare market include:

·         McKesson Corporation (U.S.)

·         Health Catalyst (U.S.)

·         Cisco Systems Inc. (U.S.)

·         MedeAnalytics, Inc. (U.S.)

·         CitusTech, Inc. (U.S.)

·         IBM Corporation (U.S.)

·         Oracle Corporation (U.S.)

·         Microsoft Corportion (U.S.)

·         Cognizant (U.S.)

·         NextGen Healthcare Information Systems (QSI Management, LLC) (U.S.)

·         Vizient, Inc. (U.S.)

 

Notable Market Developments: Big Data in Healthcare Market

·         In August 2017, NextGen Healthcare Information Systems acquired EagleDream Health, which provides services in financial, clinical, and administrative data

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/big-data-in-healthcare-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies and regulatory framework

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

 

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/big-data-in-healthcare-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Turf Growth Regulators Market | Precision Business Insights Thu, 05 Jul 2018 09:35:52 +0200 http://comunicati.net/comunicati/aziende/editoria/485306.html http://comunicati.net/comunicati/aziende/editoria/485306.html pbi pbi

 

Turf and Ornamental Crop Protection Market:

By Type of Grass ((Turf Grass, Rye Grass, Blue Kentucky Grass, Zoysia Grass, Tall Fescue, Bermuda Grass) Ornamental Grass (Feather Reed Grass, Fountain Grass, Fibre Optic Grass, Ravenna Grass, Purple Millet)), By Origin (Organic, Synthetic) By Mode of Application (Soil Treatment, Foliar Spray) Product Type (Insecticides, Herbicides, Fungicides, Others), By Geography (Latin America, North America, Asia Pacific, the Middle East and   Africa and Europe) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

 

Market Outline: Turf and Ornamental Crop Protection Market

 

Turf and ornamental crop protection substances are used for eradication and prevention of insects, microorganisms, bacterial and fungal infection of turf and ornamental plants in order to maintain proper growth of turf and ornamental crops such as grass, landscapes, horticulture plants, and decorative plants.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Dynamics: Turf and Ornamental Crop Protection Market

 

Increase in golf courses globally, growing awareness regarding quality and safety of turf and ornamental crops are expected to have positive impact on turf and ornamental crop protection market. Furthermore, increase in adoption of gardening and lawns, growing demand for the bio pesticides, inclination towards the scenic beauty, increase in tourism sector across the globe, growing initiations taken by government in maintaining the decorating plants in the countries enables propel the growth of turf and ornamental crop protection market. However, high research and development costs, lack of awareness hampers the growth of the turf and ornamental crop protection market.

 

Market Scope: Turf and Ornamental Crop Protection Market

 

The turf and ornamental crop protection market is classified on the basis of product, type of grass, origin, mode of application and regions.

Based on type of grass, market is segmented as

·         Turf Grass

o    Rye Grass

o    Blue Kentucky Grass

o    Zoysia Grass

o    Tall Fescue

o    Bermuda Grass

·         Ornamental Grass

o    Feather Reed Grass

o    Fountain Grass

o    Fibre Optic Grass

o    Ravenna Grass

o    Purple Millet

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-c654SbFYO64MsOhu

 

Based on Origin, Market is segmented as

·         Organic

·         Synthetic

Based on Product type, Market is segmented as

·         Insecticides

·         Fungicides

·         Herbicides

·         Others

Based on Mode of Application, market is segmented as

·         Soil Treatment

·         Foliar Spray

 

Market overview: Turf and Ornamental Crop Protection Market

 

·         Latin America

·         Europe

·         Asia Pacific

·         North America

·         The Middle East and  Africa

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-14mlyhjMGhVjZqa3

 

 

Region Overview: Turf and Ornamental Crop Protection Market

 

Turf and Ornamental Crop Protection Market is segmented as Latin America, Europe, Asia Pacific, North America, and The Middle East and Africa. North America and Europe holds the largest share in turf and ornamental crop protection market due to trend towards love towards decorum, nature, beauty and sports like golf and football. U.S. in North America, France and Spain in Europe hold the highest share in the regions. Asia Pacific and Latin America are emerging markets for turf and ornamental crop protection and the regions are growing at a rapid rate owing to the increase in tourism sector, growing adoption of rich sports like golf and football, increase in adoption of gardening and maintaining lawns, rise in awareness regarding the turf and ornamental inputs.

 

Competition Assessment: Turf and Ornamental Crop Protection Market

 

Some of the players in Turf and Ornamental Crop Protection Market are

·         Syngenta AG (Switzerland)

·         Dow AgroSciences LLC (U.S.)

·         The Andersons Inc. (U.S.)

·         Idemitsu Kosan Co. Ltd. (Japan)

·         FMC Corporation (U.S.)

·         Evans Turf Supplies Ltd. (New Zealand)

·         EpicoreBioNetworks Inc. (U.S.)

·         Pure AG (U.S.)

·         Eco Sustainable Solutions Ltd. (U.K.)

·         CJB Industries, Inc. (U.S.)

·         Sharda USA LLC

·         Martenson Turf Products, Inc. (U.S.)

·         Vriesland Growers Cooperative, Inc. (U.S.)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

]]>
Africa Animal Feed Market Poised to Reach USD 37,594.5 Mn by 2023 Thu, 05 Jul 2018 08:37:58 +0200 http://comunicati.net/comunicati/aziende/editoria/485300.html http://comunicati.net/comunicati/aziende/editoria/485300.html pbi pbi

Africa Animal Feed Market Poised to Reach USD 37,594.5 Mn by 2023

 

Africa Animal Feed Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period. The report analyses the market value and volume forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over the forecast period.

The Africa Animal Feed market was valued at US$ 17,697.1 Mn in 2017 and projected to reach US$ 37,594.5 Mn by 2023 owing to increase in the production of animal feed in African countries due to availability of raw materials, for instance, maize is used in the manufacturing of animal feed is a major crop for African countries, rise in the demand for healthy meat and other livestock products, launch of novel animal feed products, and entry of market players into Africa region are anticipated to propel the Africa animal feed market. However, increase in the preference for natural feed products in the rural area, the high cost of animal feed products and lack of disease awareness in underdeveloped countries are expected to hinder the growth of Africa animal feed market over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-4H8Z4LpNMLEuOnnx/

Africa Animal Feed market segmented on the basis of feed type, animal type, and country

Medicated feed accounted for higher revenue share

Based on feed type Africa animal feed market segmented into medicated feed and non-medicated feed. Medicated feed accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to rise in the incidence of various livestock diseases. However, non-medicated feed segment projected exhibit lucrative growth, which is mainly attributed to increase the focus towards the production of high-quality meat and other livestock products by livestock farmers.

South Africa leads the Africa animal feed market

PBI's Africa Animal Feed market report analyses the market in different countries such as Angola, Botswana, Congo (DR), Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland, Tanzania, Zambia, Zimbabwe, and Kenya. According to country analysis, South Africa accounted for larger value and volume share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing the to the presence of key players in the country. Kenya, Zambia, and Zimbabwe countries projected to exhibit significant growth owing to increase in the population demanding for healthy meat and other livestock products.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-c654SbFYO64MsOhu/

Feed mills establishment, customized product launches, and strategic alliances are the key strategies adopted by market players

Africa animal feed market further reveals that the key players increasingly adopting strategies such as feed mills extension, customized product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, in May 2017, Biomar group launched a complete, high-performing feed range for African catfish and tilapia for the African market.

Key player's profiles in the report are Cargill, Inc. (U.S), Nutreco N.V. (Netherlands), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Novus International (U.S), Biomin Holding GmbH (Austria)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-14mlyhjMGhVjZqa3/

Detailed Segmentation 
By Feed Type
- Medicated Feed
o Broilers Medicated Feed
o Layers Medicated Feed
o Dairy Medicated Feed
o Beef Medicated Feed
o Swine Medicated Feed
o Others Medicated Feed
- Non-medicated Feed
o Broilers Non-medicated Feed
o Layers Non-medicated Feed
o Dairy Non-medicated Feed
o Beef non-medicated Feed
o Swine Non-medicated Feed
o Others Non-medicated Feed

By Animal Type
- Farm Animals
o Broilers
o Layers
o Dairy
o Beef
o Swine
o Others
- Aquaculture
- Others

By Geography
- Africa
o Angola
o Botswana
o Congo (DR)
o Lesotho
o Malawi
o Mauritius
o Mozambique
o Namibia
o Seychelles
o South Africa
o Swaziland
o Tanzania
o Zambia
o Zimbabwe
o Kenya

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI's approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ 
https://www.precisionbusinessinsights.com

]]>
2018 - 2024 Generic Drugs market Size Thu, 05 Jul 2018 08:27:59 +0200 http://comunicati.net/comunicati/aziende/editoria/485297.html http://comunicati.net/comunicati/aziende/editoria/485297.html pbi pbi

 Generic Drugs market: A generic drug is pharmaceutical drug, which is bio equivalent to branded drug. Generic drugs are usually approved after patent expiration of patent drugs.

 Global Market Outline: Generic Drugs Market

 Global generic drugs market is driven by the prevalence of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favourable regulatory policies, expiry of the branded drugs, and growth in biosimilars segment are expected to boost the generics drugs market. Furthermore, participants in the supply chain such as wholesalers, retailers and pharmacies also benefit from the sale of the generic drugs with high margins compared to branded generics. This emerged as key driver for the growth of global generic drugs market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Generic Drugs market segmented based on therapeutic area and distribution channel

 

Based on therapeutic area, global generic drugs market is segmented into

·         Cardiovascular

·         CNS

·         Antibiotics

·         Oncology

·         Gastrointestinal

·         Hormones

·         Pain Management

·         Others

 

Based on distribution channel, global generic drugs market is segmented into

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-c654SbFYO64MsOhu

 

 

Generic drugs market is highly fragmented market, presence of large players and small players. To improve their market position in generic drug market companies are adopting strategies like expanding their market presence through collaboration and entering into new markets. For instance, in January 2017, Medical inhaler company Vectura Group PLC collaborated with Sandoz, a division of Novartis AG, to develop a generic version of an inhaler therapy for asthma and COPD (chronic obstructive pulmonary disease). In January 2016, Momenta collaborated with Mylan Laboratories for the development, manufacture and commercialization of six of its biosimilar candidates, including M834, Orencia (abatacept) a biosimilar candidate. Mergers and acquisitions are key strategies adopted by various market players. For instance, in August 2016, Teva Pharmaceutical Industries Ltd Acquired Allergen’s generic business Actavis Generics to expand their product, R&D portfolio and geographical footprint in generic market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically generic drugs market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America generic drugs market is expected to grow at significant rates owing to availability of more number of generics, increase awareness about the generic drugs and favourable regulatory policies and acts such as Affordable Care Act 2010. In Europe region, Belgium and UK expected to grow at notable rates owing to prevalence of chronic diseases, increase in investment on biosimilars, and increase awareness about generic drugs. Asia Pacific Region expected to be fastest growing due to increased government initiatives in usage of generic drugs and increase in awareness about generic drugs. Especially emerging countries like India government initiating different policies and schemes to boost the usage of generic drugs, For instance, Government of India taken an initiative of opening Jan aushadhi stores to make available quality generic medicines at affordable prices to all citizens.

 

Some of the market players in generic drugs market are Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries, Ltd. (Israel), Dr Reddy’s Laboratories (India), Novartis AG (Sandoz International GmbH) (Switzerland), Apotex Holdings Inc. (Canada), Endo International plc (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc., (Janssen Pharmaceutica) (U.S.), Lupin Limited (India), Merck & Co, Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Nexus Pharmaceuticals (U.S.), and Novo Nordisk (Denmark) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

]]>
Global Psoriasis Treatment Market poised to reach US$ 20,388.2 Mn by 2023 Thu, 05 Jul 2018 08:25:29 +0200 http://comunicati.net/comunicati/aziende/editoria/485296.html http://comunicati.net/comunicati/aziende/editoria/485296.html pbi pbi  The Global Psoriasis Treatment Market poised to reach US$ 20,388.2 Mn by 2023 with a significant CAGR over the forecast period (2018-2023) owing to increase in prevalence of the psoriasis conditions all across the globe

 

Psoriasis Treatment Market: By drug class (TNF Inhibitors, Vitamin D Analogues, Interleukin Blockers, Topical Corticosteroids, Monoclonal Antibodies, Other) By psoriasis type (Plaqu Psoriasis, Guttate Psoriasis, Flexural Psoriasis, Inverse Psoriasis, Psoriatic Psoriasis), By route of administration (Oral,Topical, Parenteral), By distribution channel (Hospital Pharmacies, Retail Pharmacie, Online Pharmacies) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Psoriasis is a perpetual immune system sickness portrayed by irregular development of the skin cells. It frames skin fixes over the skin and it isn't infectious. Psoriasis skin patches are red and bothersome. There are diverse sorts of psoriasis specifically guttate psoriasis, plaque psoriasis, pustular psoriasis, erythrodermic psoriasis and reverse psoriasis. Plaque psoriasis is normal and constitutes around 90% of psoriasis cases. The conclusion of psoriasis is normally made by getting data from the physical examination of the skin, restorative history, and pertinent family wellbeing history. Psoriasis influences skin over the elbows, knees, and scalp and is regularly irritated. Albeit any region might be included, it has a tendency to be more typical at locales of erosion, scratching, or scraped spot. At present, there was no cure for psoriasis. Be that as it may, treatment is centered around curing the side effects. Treatment may incorporate steroid creams, vitamin D3 cream, UV light, and immunosuppressants.

 

Global psoriasis treatment market is driven by increase in smoking and alcohol consumption trends globally. Increased spending on medicines and escalating health care expenditure are the key growth drivers of the market. Psoriasis treatment mainly treated by topical agents only. The recent launch of systemic products into the market expected to drive the growth of the market. However, high cost of the drugs and side-effects associated with the existing medication for psoriasis are expected to hinder the psoriasis treatment market during the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Psoriasis treatment market segmented on the basis of drug class, type, route of administration, and distribution channel

 

Based on drug class, global psoriasis treatment market is segmented into

·         TNF Inhibitors

·         Vitamin D Analogues

·         Interleukin Blockers

·         Topical Corticosteroids

·         Monoclonal Antibodies

·         Others

 

Based on type, global psoriasis treatment market is segmented into

·         Plaque Psoriasis

·         Guttate Psoriasis

·         Flexural Psoriasis

·         Inverse Psoriasis

·         Psoriatic Psoriasis

 

Based on route of administration, global psoriasis treatment market is segmented into

·         Oral

·         Topical

·         Parenteral

 

Based on distribution channel, psoriasis treatment system is segmented into

·         Hospital Pharmacy

·         Retail Pharmacy

·         Online Pharmacy

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Psoriasis treatment market is expected to show significant growth rate owing to prevalence rates and severity of the disease. According to World Health Organization (WHO), 1.3%-34.7% of psoriasis patients develop chronic psoriatic arthritis, which may lead to joint deformations and disability. World Health Organization (WHO) also predicts that psoriasis affects about 100 million people with prevalence rates of 0.09% to 11.43% in different countries. The most common type of psoriasis is plaque psoriasis, affecting 90% of all psoriasis cases. Market players are focusing on R&D to develop new drugs and treatments for psoriasis. The market has a handful of drugs and dominated by generics and biologics. Market players heavily influencing the treatment decisions. Due to the entry of biosimilars into the market, there is availability of cheaper drugs to treat psoriasis and it leading to increased availability and increase market size. In addition, market has drug pipelines which are expected to boost the psoriasis treatment market during forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, psoriasis treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts largest market in the psoriasis treatment market due to high prevalence of the disease. According to American Academy of Dermatology, approximately 7.5 Mn people in the United States have psoriasis. In Europe, the psoriasis treatment market is expected to grow at significant rate due to factors such as increased prevalence and growing awareness about skin diseases and recent launch of biosimilars such as elerzi, amzevita. In Asia-Pacific region, India and China are expected to be fastest growing market due to developing infrastructure and rapid growth in awareness and available treatment options for psoriasis.

 

Some of the market players in psoriasis treatment market include Amgen Inc. (U.S), Eli Lilly and Company(U.S), Novartis AG (Switzerland), Merck & Co., Inc. (U.S), Johnson & Johnson Services, Inc., (U.S) Pfizer, Inc. (U.S), AstraZeneca (U.K), AbbVie Inc. (U.S), LEO Pharma A/S (Denmark) and Biogen (U.S) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/

 

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

 

 

 

 

 

 

]]>
UK Dermal Fillers Market To Be Valued US$ 80.0 Mn by 2023 Thu, 05 Jul 2018 08:22:22 +0200 http://comunicati.net/comunicati/aziende/editoria/485295.html http://comunicati.net/comunicati/aziende/editoria/485295.html pbi pbi

UK Dermal Fillers Market To Be Valued US$ 80.0 Mn by 2023

 

Analyst Speak: UK Dermal Fillers Market

 

The UK Dermal Fillers Market poised to reach US$ 80.0 Mn by 2023 with CAGR of 8.2% over six years forecast period 2018-2023 owing to growing demand for non-surgical aesthetic treatments

 

Precision Business Insights (PBI) in its report titled “UK Dermal Fillers Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023” assesses the market performance over six years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The UK Dermal Fillers market was valued around US$ 50.0 Mn in 2017 and projected to reach US$ 80.0 Mn by 2023 owing to wider products availability, growing adoption dermal fillers by healthcare fraternity, and inherent benefits of dermal fillers. According to a survey conducted by Whatclinic.com there was 24% increase in the inquiries about the dermal fillers from only 2015 to 2016. Furthermore, procedures are gaining traction due to its affordability and non-invasiveness. According to The British Association of Aesthetic Plastic Surgeons (BAAPS), the number of British citizens undergoing cosmetic surgery fell in 2016 to the lowest number in a decade, while non-surgical cosmetic treatments continue to rise.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uk-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

 

UK Dermal Fillers market segmented on the basis of product type, ingredient type, application, and distribution channel

Hyaluronic acid dermal fillers accounted for larger revenue share in UK dermal fillers market

Based on ingredient type UK dermal fillers market segmented into Hyaluronic Acid (HLA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA), and Collagen dermal fillers. Hyaluronic acid dermal fillers accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to its biocompatible nature and wider product availability in the market. However, Polymethylmethacrylate dermal fillers segment projected exhibit lowest growth rate compared with other dermal fillers, which is mainly attributed to its long-term adverse effects.

Distributors influence on customer product choice

PBI interviewed several distributors/wholesalers and aesthetic practitioners to understand the buying behavior and ascertain the critical factors influencing purchasing decision. Several distributors are found to be offering products at discounted prices to lure the customers. Moreover, distributors offering free products upon the bulk purchase ranging from 50 – 100 boxes depending on the value and volume of the product. Several distributors noted that they suggest cheaper alternative to the current products to assist the customers in purchasing decision. New services offered by distributors helping them to gain the large customers and assisting in wide product offerings to the prescribers. For Instance, DigitRx, Digital prescription services by church pharmacy. DigitRx! Specifically designed for medical professionals in the aesthetic industry, the system makes ordering online fast, easy and convenient.

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uk-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

 

Key players profiled in the UK dermal fillers market report include Galderma S.A, Merz Pharma, Allergan plc., ADODERM GmbH, Teoxane SA, Sinclair Pharma plc., and HA-DERMA

Detailed Segmentation

By Product Type

·         Absorbable Dermal Fillers

·         Non-Absorbable Dermal Fillers

 

By Ingredient Type

·         Hyaluronic Acid (HLA)

·         Poly-L-Lactic Acid (PLA)

·         Calcium Hydroxylapatite (CaH)

·         Polymethylmethacrylate (PMMA)

·         Collagen

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/uk-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

 

 

By Application

·         Aesthetic Restoration

·         Wrinkle Reduction

·         Dentistry

·         Reconstructive Surgery

 

By Distribution Channel

·         Retail Pharmacies

·         Beauty/Aesthetic Clinics

·         Online Pharmacies

 

By Geography

·         UK

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/uk-dermal-fillers-market/

 

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @
https://www.precisionbusinessinsights.com

 

]]>
Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 Thu, 05 Jul 2018 08:20:31 +0200 http://comunicati.net/comunicati/aziende/editoria/485294.html http://comunicati.net/comunicati/aziende/editoria/485294.html pbi pbi

 Dermal Fillers Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

The  Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 and growing at a significant CAGR over six years forecast period 2018-2023 owing to increase in the incidence of cosmetic skin issues and awareness among young population

 

 

Dermal fillers are implants that are regulated as the medical devices by U.S.FDA. Dermal fillers are used as effective treatment for folds correction, wrinkles and deep lines on the face. Dermal fillers can be used for anti-aging practices to remove folds and wrinkles in nasolabial, and cheek area, lines and wrinkles around eye and volume loss in chin. Dermal fillers are the injectable gels that are composed of synthetic and natural substances like hyaluronic acid. Dermal fillers pump and lift the sagged skin for restoring lost collagen because of the aging.

 

Increase in patients with different cosmetic skin issues like deep lines, wrinkles and scars, diet imbalance are the major factors boosting the revenue growth of the dermal fillers market. As per the World Health Organization (WHO), more than 2 Bn of the global population will be over the age of 60 by the year 2050, WHO stated that the growth of the facial filler market is directly proportional to the growing geriatric population, who experience loss of fluid and collagen in the skin as they grow older, that results in the development of wrinkles on the face and neck areas. Dermal fillers is less painful and non-invasive method for treating various facial problems and aesthetic treatments for other parts of the body. High cost of the procedure and infections associated with dermal fillers is the major market constraint that hinders the growth of the dermal fillers market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Derma fillers market segmented on the basis of product type, ingredient and distribution channel

 

On basis of product type, the dermal fillers market is segmented into

·         Absorbable Dermal Fillers

·         Non-Absorbable Dermal Fillers

 

On basis of ingredient, the dermal fillers market is segmented into

·         Hyaluronic acid (HLA)

·         Poly-L-Lactic Acid (PLA)

·         Calcium hydroxyl apatite (CaH)

·         Polymethylmethacrylate (PMMA)

·         Collagen

·         Others

 

On basis of distribution channel, the dermal fillers market is segmented into

·         Retail Pharmacies

·         Drug Stores

·         Beauty Clinics

·         Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

 

 

The global dermal filler market is expected to grow at significant rate owing to advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing dermal fillers to patients. Further, the market is witnessing various acquisitions, collaborations, and mergers among major players. A NAMCS (The National Ambulatory Medical Care Survey) reported that from 1995 to 2003, soft tissue fillers 18.4% constituted office-based cosmetic procedure visits. 90% of office-based cosmetic procedures were performed on Caucasian patients and 10% on non-Caucasian patients. The American Society of Plastic Surgeons in its 2007 Cosmetic Demographics by Patient Ethnicity reported that injectable fillers are one of the three most commonly adopted procedures among, Hispanics, Asian Americans, and African-Americans who seeks cosmetic procedures. As per to the statistics of the American Society of Aesthetic Plastic Surgery, in 2015, dermal filler cosmetic treatments has increased by 8%.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

 

 

Based on the geographical regions dermal filler market is segmented into five key regions Latin America, North America, Asia-Pacific, Europe, Middle East and Africa. North America holds largest share globally followed by Europe, and Asia Pacific due to the high occurrence of various skin problems. In Asia-Pacific, the Australian and Chinese markets for facial injectable will sustain the fastest growth through 2014. The Asia-Pacific facial injectable market comprising sales of hyaluronic acid (HA) dermal fillers, particle and polymer fillers (PPFs), and collagen fillers will grow significantly due to increased physician adoption of profitable facial injectable treatments in their practices and growing patient demand for less invasive cosmetic procedures.

 

Some of the players in the dermal fillers market are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), MERZ PHARMA GMBH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland),  AQTIS Medical (Canada), and Suneva Medical (U.S.)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
2018 - 2024 Optical Coherence Tomography Market Thu, 05 Jul 2018 08:14:26 +0200 http://comunicati.net/comunicati/aziende/editoria/485292.html http://comunicati.net/comunicati/aziende/editoria/485292.html pbi pbi

 The Global Optical Coherence Tomography Market was valued around US$ 735.3 Mn in 2017 and growing at a significant CAGR over ten years forecast period 2018-2027 owing to increase in the demand for non-invasive diagnostic methods

 

Optical Coherence Tomography Market: By Product Type (Portable/Handheld, Table Top) By Application (Ophthalmic Diagnosis, Dermatology) By Technology (Spectral Domain OCT, Swept Source OCT) By End-User (Hospitals, Clinics, Others)  By Geography (North America , Europe , Asia-Pacific , Latin America , The Middle East and Africa (MEA)– Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Market Dynamics: Optical Coherence Tomography Market

 

Optical Coherence Tomography (OCT) is an emerging innovative medical technology, which enables offer high resolution, cross sectional tomographic images of biological systems. OCT is a type of optical biopsy, does not require removal of tissue specimen as conventional histopathology. Burgeoning geriatric population around the world is expected to accelerate demand for OCT market. In accordance with WHO, population above 65 years were 13% in 2010, and expected to reach 53% by 2020. Furthermore, increase in prevalence of chronic diseases such as diabetes, diabetic retinopathy, cardiovascular diseases, skin cancers, and prostate cancer are witnessed to catapult the market growth of OCT. Moreover, presence of favorable reimbursements, advancements in the technology, and increase in R&D investments are further propels the OCT market. On the other hand, lack of awareness, high installation costs, high cost of testing, and dearth of skilled professionals restrains the growth of OCT market.

 

 

A sample of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

 

 

Market Scope: Optical Coherence Tomography Market

 

Optical Coherence Tomography market is segmented on the basis of type and geographical regions

Based on the Technology, Optical Coherence Tomography market is segmented into the following

 

·         Fourier Domain OCT

o    Swept-Source OCT or Optical Fourier Domain Imaging

o    Spectral Domain OCT

 

Based on the Device Type, Optical Coherence Tomography market is segmented into the following

 

·         Tabletop OCT Devices

·         Handheld OCT Devices

 

Based on the Application, Optical Coherence Tomography market is segmented into the following

 

·         Glaucoma

·         Diabetic Retinopathy

·         Oncology

·         Dermatology

·         Others

 

Based on the End User, Optical Coherence Tomography market is segmented into the following

·         Hospitals

·         Ambulatory Surgical Centres

·         Diagnostic Centres

·         Research Institutes

 

 

To view TOC of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Optical Coherence Tomography Market

 

Geographically, Optical Coherence Tomography market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is expected to account for major revenue share for OCT followed by Europe due to high adoption of state-of-art technologies, increase in the complications such as diabetic retinopathy, skin cancers, well established healthcare infrastructure, favorable reimbursement policies, and rapid increase in geriatric population. Asia Pacific and Latin America are anticipated to show unprecedented growth rate, owing to increase in awareness among people, huge population pool, rise in number of geriatric patients, presence of emerging economies such as Brazil, India, China, Japan.

 

 Need more information about this report @

 https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Optical Coherence Tomography Market

 

Key Players profiles in the global Optical Coherence Tomography market include

 

·         Leica Microsystems (Germany)

·         Carl Zeiss Meditec AG (Germany)

·         Topcon Corporation (Japan)

·         Novacam Technologies Inc. (Canada)

·         Heidelberg Engineering GmbH (Germany)

·         Thorlabs Inc. (U.S)

·         OPTOPOL Technology S.A.

·         Agfa Healthcare (Belgium)

·         NIDEK CO., LTD (Japan)

·         Optovue, Incorporated (U.S.)

 

Notable Market Developments: Optical Coherence Tomography Market

 

·         In April 2017, Optovue launched OCT angiography for ophthalmology to provide high resolution and peripheral visualization of eye vasculature during detection of eye macular edema.

 

·         In October 2016, Optopol Technology and BiB Ophthalmic Instruments, an UK based company entered into a partnership to distribute OCT systems in UK.

 

·         In August 2016, Throlabs introduced two modified components for OCT super luminescent diode and polarization dependent isolator.

 

·         In 2013, Car Zeiss launched HD-OCT 5000

 

Key Features of the Report:

·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

 

]]>
2018 - 2024 3D Printing Medical Devices Market Thu, 05 Jul 2018 08:08:51 +0200 http://comunicati.net/comunicati/aziende/editoria/485288.html http://comunicati.net/comunicati/aziende/editoria/485288.html pbi pbi

 3D Printing Medical Devices Market: By Application (Surgical Guides, Implants, Surgical Instruments, Bioengineerin, Others), By Technology (Droplet Deposition (DD), Photopolymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, Others), By Raw Materials (Metals, Polymers, Ceramics, Biological Cells, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres), and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

3D Printing Medical devices market

3D is 3-dimensional of a structure having height, width, and depth (length). A structure or a picture is drawn on a paper can be flat to the human eye, with 3D model or drawing, the picture gets more depth and can be viewed as 360°. 3D modeling is getting into every market leaving behind no stone unturned. With the demand for more and more 3D structure, 3D printing has taken over the market. One such market is medical industry, 3D printing medical devices market is filled with innovations and are ready to amuse the customers and buyers.

The 3D printing medical devices market is also walking through many others branches of medical such as healthcare, implants, drug manufacturing, dental work, etc. 3D printing is also called as additive manufacturing. Due to demand for personalized medical care from individuals, 3D digital files are created. The material used for 3D printing medical devices depends on the need of the individual. For example, dental crowns required to be made up of metal or ceramics for dental implants while 3D models are made to practice a complex surgery.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-3d-printing-medical-devices-market/#ulp-4H8Z4LpNMLEuOnnx

3D printing devices market study

A 3D printing is still new and emerging in the market. The production does require a lot of study and investment. The initial stages involve design and patent of the 3D medical devices which should be cost-effective during and after the manufacturing and selling point of view. Surely 3D printing is bringing a lot of innovation and newness to the table it and it is wiping out the traditional prototype processing.  Increase in demand from medical and pharma industries, 3D printing medical devices will create a market of its own. The awareness will boost the sales and manufacturing of the 3D printing equipment market.

The global market is open and accepting the 3D printing medical devices. North America is the leading consumer of 3D printing in the healthcare industry followed by Europe. The other continents such as Asia-Pacific, the Middle East, Africa, and Latin America are in following the market trends. With rising awareness, demand, and increase in startup companies and also government taking keen interest to increase the 3D printing applications in the healthcare industry.

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-3d-printing-medical-devices-market/#ulp-c654SbFYO64MsOhu

3D printing medical devices investment

The 3D printing medical devices market is growing tremendously due to its demand in the healthcare industry. Public and private investments are increasing due to technological advancements in the market. The investment in 3D printing is on a huge scale ranging from patent, copyright policies, regulatory frameworks, 3D printers, designs are just a few names under the roof. But with the constant demand, more and more companies are diving into the 3D printing medical devices market and marking their own place.

3D printing medical devices materials and its applications

Depending on the specific need and applications, the 3D devices are made accordingly. On the basis of the applications, the 3D printing medical devices market is divided into surgical instruments, implants such as dental, orthopedic, Cranio-maxillofacial, etc., bioengineering and others.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-3d-printing-medical-devices-market/#ulp-14mlyhjMGhVjZqa3

For all of the above, raw materials used for 3D printing medical devices market are as follows-

§  Polymers, metals, ceramics and biological cells.

There are different technologies used for 3D printing medical devices market. Some are listed below-

·         Droplet Deposition (DD)

o    Fused deposition modeling (FDM) technology

o    Low-temperature Deposition Manufacturing (LDM)

o    Multiphase Jet Solidification (MJS)

·         Photo polymerization

o    Stereo lithography (SLA)

o    Continuous Liquid Interface Production (CLIP)

o    Two-Photon Polymerization (2PP)

·         Laser Beam Melting

o    Selective Laser melting (SLM)

o    Selective Laser Sintering (SLS)

o    Direct Metal Laser Sintering (DMLS)

·         Electronic Beam Melting (EBM)

·         Laminated Object Manufacturing

·         Others

 And to sum up, by the end user, 3D printing medical devices market has following users-

§  Hospitals, ambulatory surgical centers and specialty clinics.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-3d-printing-medical-devices-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

]]>
Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:48 +0200 http://comunicati.net/comunicati/aziende/editoria/480858.html http://comunicati.net/comunicati/aziende/editoria/480858.html pbi pbi

Chagas Disease Management Market Projected To Grow With Significant CAGR Over The Forecast Period

Global chagas disease management market: Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen lymph nodes, fever, headache, and local swelling at the site of the bite. The chronic symptoms will appear after 8-12 weeks that may include expansion of ventricles leading to heart failure, irregular heartbeat, difficulty in swallowing, and abdominal or colon pain.

 

Rise in the prevalence of Chagas disease due to unhygienic conditions are factors leading to the growth of market. In addition, increase in the R & D of new products are one of the main factors for the market growth. However, lack of awareness regarding the Chagas disease treatment, a limited number of approved products in the current market, and supply chain issues with Chagas disease drugs will hamper the market growth.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-4H8Z4LpNMLEuOnnx

 

The Chagas disease management market is categorized as under-

1.      Type of treatment

·         Anti-parasitic treatment

·         Symptomatic treatment

2.     Drug type

·         Benznidazole

·         Nifurtimox

3.     End-users

Hospital, Online and retail pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions, the Chagas disease management market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Latin America is the major center for Chagas disease and gradually developing in the rest of world owing to the population mobility from Latin America. Less number of products available in the market for treatment, and poor diagnostic methods to detect in the Latin America region are the major challenges for the Chagas disease management market in this region. North America and Europe are the key regions for Chagas disease management market owing to increase in the prevalence of Chagas disease.

 

Some of the key players in Chagas disease management market are AstraZeneca (U.K), Bayer AG (Germany), Daiichi Sankyo Company Ltd (Japan), Eisai Co Ltd (Japan), GlaxoSmithKline Plc. (U.K), Grupo Praxis Pharmaceutical SA (Spain), Kancera AB (Sweden), Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Oblita Therapeutics BVBA (Belgium), and Sanofi Aventis (France) to name a few. In 2017, Daiichi Sankyo Company Limited and Drugs for Neglected Diseases initiative (DNDi) are collaborated to form a joint research with regard to a new research program, the hit-to-lead project to develop the drugs for Chagas disease and Leishmaniasis.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/#ulp-14mlyhjMGhVjZqa3

 

 

Chagas disease management market is still in the budding stage. Currently, very few players are actively involved in the development of new products for the treatment. Several products are in pipeline that may enter the market near future.  Increase in R & D for new products, acquisitions & mergers, collaborations and providing funds to various organizations can fuel the market growth for Chagas disease. For instance, in 2012, Japan’s Astellas Pharma signed an agreement with the Drugs for Neglected Diseases initiative (DNDi) to collaborate on drug discovery research for three neglected tropical diseases: leishmaniasis, Chagas disease, and sleeping sickness.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Anti-Retroviral Drugs Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:40 +0200 http://comunicati.net/comunicati/aziende/editoria/480857.html http://comunicati.net/comunicati/aziende/editoria/480857.html pbi pbi

Anti-Retroviral Drugs Market Projected To Grow With Significant CAGR Over The Forecast Period

Retroviruses are a single stranded RNA containing virus. Retrovirus use enzyme called reverse transcriptase to copy their RNA into DNA of the host cell. The retrovirus integrates its viral DNA into DNA of the host cell, which allows the retrovirus to replicate. Retroviruses can cause different outcomes for the infected cell.

 

Retroviruses are capable of inducing autoimmune, immunosuppressive, and neurological illnesses. Some retroviruses, such as the spumaviruses and lentiviruses are capable of directly killing cells. Acquired immune deficiency syndrome (AIDS) caused by retrovirus known as Human Immunodeficiency Virus (HIV) and T-Cell leukemia caused by human T lymphotropic virus (HTLV).

 

Antiretroviral drugs are the drugs that acts or inhibit certain process in viral replication and inhibits further worsening of the diseases. Globally antiretroviral drugs market driven by increased cases of retroviral infections such as especially HIV/AIDS. The higher prevalence of HIV owing to the various factors such as lack of availability of medication for the treatment of HIV infection, promising pipeline drugs, increased funding by the government are expected to grow the antiretroviral drugs market. However, high costs of R & D and strict regulatory procedures are hindering the global antiretroviral drugs market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global antiretroviral drugs market is categorized as under- 

1.      Drug class

·         Nucleoside Reverse Transcriptase Inhibitors (NRT’s)

·         Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)

·         Protease Inhibitors

·         Integrate Inhibitors

·         Fusion Inhibitors

·         Chemokine Receptor Inhibitors

·         Others

2.     Route of administration

·         Oral

·         Parenteral

3.     End-users

·         Hospital, retail, online pharmacies and others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

And lastly on the basis of geographical regions, the global antiretroviral drugs market is divided into five key regions- North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. North America antiretroviral market is driven by combination drug therapies by key players in this region. Asia Pacific antiretroviral drugs market expected to be fastest growing due to developing healthcare infrastructure and increased awareness by government and non-government organization for retroviral diseases especially HIV/AIDS. The Middle East and Africa region is expected to be key region owing to availability of large pool of patients with retroviral diseases. However, poor healthcare infrastructure and lack of awareness related to retroviral diseases among healthcare professionals expected to hamper market growth in this region.

 

Some of the key players in the global antiretroviral drugs market are Abbott Laboratories (U.S.), AstraZeneca plc (U.K.), Modified Polymer Components, Inc. (Bristol-Myers-Squibb) (U.S), Gilead Sciences (U.S.), GlaxoSmithKline Plc (U.K.), and F. Hoffmann-La Roche AG (Switzerland) to name a few. In 2016, ViiV Healthcare (Pfizer and GlaxoSmithKline’s joint venture) received U.S. FDA approval to market Selzentry for the treatment of CCR5-tropic HIV-1 infection, in combination with other antiretroviral agents.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-14mlyhjMGhVjZqa3

 

Market players are adopting strategies like mergers and acquisitions, collaboration with government and non-government organizations to educate the people and increase awareness related to retroviral diseases. Drugs such as Doravirine (Merck & Co.), Fostemsavir (Bristol-Myers Squibb), etc. are pipeline drugs which are expected to grow the antiretroviral drug market to a significant rate.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Breast Cancer Treatment Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:31 +0200 http://comunicati.net/comunicati/aziende/editoria/480856.html http://comunicati.net/comunicati/aziende/editoria/480856.html pbi pbi

Breast Cancer Treatment Market Projected To Grow With Significant CAGR Over The Forecast Period

Breast cancer is a disease where uncontrolled growth of malignant cells in the breast tissue that is most commonly occurs in female than men. The common signs and symptoms associated with breast cancer include change in the breast shape, lumps in the breast, dimpling of skin, and red scaly patches on the skin. Treatment of breast cancer depends on various factors such as the type of breast cancer, the size of a tumor, stage of breast cancer and the grade of cancer cells. Breast cancer can be treated by various therapies such as radiation therapy, chemotherapy, hormone therapy, targeted therapy and bone-directed therapy.  The breast cancer commonly occurs due to drinking alcohol, being female, obesity, ionizing radiation, genetics and older age, etc. The breast cancer is diagnosed by taking a biopsy of lump. After the diagnosis, further tests are carried to determine the cancer stage and suitable treatment for the disease.

 

The global breast cancer treatment market is expected to increase with significant rate due to increasing breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Furthermore, increased investments in R & D, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology will boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is categorized on the basis of - 

1.      Drug class

·         Anthracyclines

·         Antimetabolites

·         Epothilones

·         Taxanes

·         Alkylating agents

·         Hormonal therapy

·         Aromatase inhibitors

·         Selective estrogen-receptor modulators

2.     End-users

·         Hospital, retail and online pharmacies 

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, the global breast cancer drugs market has five major regions- North America, Europe, Latin America, Middle East and Africa and Asia-Pacific. North America dominates the breast cancer treatment market due to increase cases of breast cancer disease, increase in old age female population, and favorable government initiatives for the treatment. Europe holds a major share in breast cancer treatment market owing to rise in the prevalence and incidence of breast cancer cases. Most of the pharmaceutical companies in breast cancer treatment market are focused on R & D, strategic collaborations, acquisitions & mergers, and product launches for the development in the breast cancer treatment market.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the key players in breast cancer drugs market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc. (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few. In 2017, U.S. FDA approved the Puma Biotechnology’s Nerlynx (Neratinib) for the treatment of HER2-positive breast cancer in early stage. And in the same year, AstraZeneca received an approval from European Commission (EC) for Faslodex (fulvestrant) for the breast cancer treatment.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

]]>
Branded Generics Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:22 +0200 http://comunicati.net/comunicati/aziende/editoria/480855.html http://comunicati.net/comunicati/aziende/editoria/480855.html pbi pbi

Branded Generics Market Projected To Grow With Significant CAGR Over The Forecast Period

 

This report studies branded generics market dynamics in emerging markets and developed markets elaborately to identify the current trends, future opportunities, historic market and possible challenges to the key stakeholders operating in the market. In addition, branded generics market report includes new product introductions, regulatory scenario, and competition analysis to analyze the market competition.

 

Branded generics market report deals with detailed market outlook in emerging markets such as Brazil, Russia, China, India, and other Eastern Europe, Latin American countries. Moreover, PBI analyzed branded generics market to better equip clients with possible investment opportunities across the emerging markets. The market for branded generics projected to reach US$ 350.0 billion by 2023. Owing to the widespread prevalence of lifestyle and chronic diseases like diabetes and cardiovascular diseases especially in the emerging market countries, the growth of the branded generics is inevitable.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global branded generics market is categorized as-

1.      Diseases Indication

·         Cardiovascular Diseases

·         Diabetes

·         Cancer

·         Neurological Disorders

·         Gastrointestinal Diseases

·         Dermatology Diseases

·         Others

2.     Route of Administration

·         Oral

·         Parenteral

·         Topical

·         Others

3.     End-users

·         Hospital, retail and online Pharmacies, and drug stores.

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-c654SbFYO64MsOhu

 

 And lastly, on the basis of geographical regions, the global market for branded generics is divided into five regions- North America, Europe, the Middle East & Africa, Latin America and Asia-Pacific.

 

Developed pharmaceutical markets like North America, Europe, and Japan has been witnessing relatively stagnant market growth in comparing with developing markets owing to fewer new product approvals from the regulatory bodies. This has been led to shift the focus by several multinational pharmaceutical companies from matured markets to developing markets to tap unreached and budding market opportunities. 

 

Asia-Pacific accounts for larger market revenue share in global branded generics market. The Asia-pacific region is leading the global Branded Generics market in terms of revenue owing to higher allowance for healthcare expenditure and lack of universal health coverage. Moreover, countries like India, China, and ASEAN countries have better growth opportunities for the existing and new players in the market. Regions such as Asia Latin America and Eastern Europe projected to grow at significant rate. Some of the key market players in the developing market regions are Abbott Laboratories (U.S.), Apotex Inc. (Canada), AstraZeneca (U.K), Reddy’s Laboratories Ltd. (India), GlaxoSmithKline plc (U.K), Mylan N.V. (U.S.), Pfizer Inc. (U.S), Novartis AG (Switzerland), Sanofi (France), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd (Israel), Valeant Pharmaceuticals International, Inc. (Canada).

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-14mlyhjMGhVjZqa3

 

 

Market players are focusing on mergers and acquisitions, strategic alliances, and product diversification to increase the geographic presence in global Branded Generics market. Moreover, players are entering into a distribution agreement with local pharmaceutical companies to overcome the market access barrier in developing regions.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Blood Grouping Reagents Market Projected To Grow With Significant CAGR Over The Forecast Period Mon, 28 May 2018 11:01:10 +0200 http://comunicati.net/comunicati/aziende/editoria/480854.html http://comunicati.net/comunicati/aziende/editoria/480854.html pbi pbi

Blood Grouping Reagents Market Projected To Grow With Significant CAGR Over The Forecast Period

Global blood grouping reagent market: Blood grouping reagents are the essential testing reagents which are used by hospitals and the blood banks. They are used in determination and identification of antibody type in patient’s and donors’ blood, in order to ensure effective and safe transfusion of blood. Blood grouping reagents are indicated for determination of the Rh type and ABO blood group from donor’s blood. Blood grouping reagents are made up of antibodies which are derived from in-vitro cultures of hybridomas of human and murine origin and also includes antigens to act against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.

 

Factors such as rising in the prevalence rate of various diseases, dire need for the blood during surgical procedures, rise in the government initiatives about necessity of the donation of blood, safe blood transfusion, campaigns on blood donation are propelling the growth of blood grouping reagents market. However, lack of awareness, paucity of trained and skilled professionals which may lead to risks in transfusion hence, diminishing the growth of blood bank reagents globally.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global blood grouping reagent market is categorized as under-

1.      Product

·         Consumables

·         Instruments

2.     Technique

·         PCR-based and Microarray Technique

·         Assay-Based Techniques

·         Massively Parallel Sequencing Techniques

·         Other Techniques

3.     Test type

·         Antibody Screening

·         HLA Typing

·         Cross-Matching Tests

·         ABO Blood Tests

·         Antigen Typing

4.     End-users

Hospitals, Blood Banks and Clinical Laboratories.

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, blood grouping reagents market is divided into five major regions- Latin America, North America, Asia Pacific, Europe, the Middle East and Africa. North America holds largest market share due to favorable reimbursement policies for surgeries, and rising incidence of the major blood disorders. Asia-Pacific market is anticipated to show significant growth rate due to rise in incidence and prevalence rate of chronic disorders in Asian countries. Some of the players in the blood grouping reagents market are Grifols, S.A. (Spain), Bio-Rad Laboratories, Inc. (U.S.), Immucor, Inc. (U.S.), Quotient, Ltd. (U.S.), ), Novacyt Group (France), Ortho Clinical Diagnostics, Inc. (U.S.),  BAG Healthcare GmbH (Germany), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France). And DIAGAST (France). In 2017, Bio-Rad Laboratories, Inc., received U.S. FDA clearance for IH-1000 blood typing instrument to market in the US. In the same year, Immucor, Inc., launched MIA FORA NGS FLEX HLA Typing Assay which provides comprehensive coverage up to 11 HLA genes.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/#ulp-14mlyhjMGhVjZqa3

 

Blood grouping reagents are the vital tools in diagnostic laboratories for blood group serology. Rise number of blood transfusion procedures is anticipated to pose great demand for the blood grouping reagents. In addition to this extended use of blood group reagents for the purpose of research is anticipated to propel the market growth of blood grouping reagents. Every day in U.S., approximately about 36,000 units of RBC, 7,000 units of platelets and 10,000 units of plasma are required and roughly 21 million blood components are transfused every year in U.S.